Anuh Pharma plans expansion, to avail Rs. 75 crs loan for assets
BOARD
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 13 Oct 2026, 06:42 PM IST · BSE ID: 497d3dbf-73f3-4b78-aeed-6a2c8795ba00
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors agreed to buy new factory equipment and borrow up to ₹75 Crores to make more products.
🤖 AI Summary
- Anuh Pharma board approves investment in manufacturing assets for capacity expansion.
- Company plans to avail a loan of up to ₹ 75 crs for asset purchase.
- Expansion aims to increase overall production capabilities of the company.
- Board meeting concluded with approval of both expansion and financing proposals.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Loan amount approved
up to ₹ 75 crs
🏢 How This Affects the Company
This expansion is intended to increase the company's production capacity, potentially enabling it to take on more orders and grow revenue.
Availing a loan of up to ₹ 75 crs will increase the company's debt levels, impacting its leverage and interest expenses.
The investment in new manufacturing assets will enhance the company's production capabilities and operational scale.
Taking on significant debt to finance expansion introduces financial risk associated with repayment obligations and interest costs.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders regarding this board decision.
👤
Who Is Affected
All shareholders are indirectly affected by management's strategic decision to invest in expansion and take on debt.
🔍
Management Signal
Management is signalling a commitment to growth and increasing production capabilities through asset acquisition.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Final terms and conditions of the loan facility.
Details of the manufacturing assets to be acquired.
Company's subsequent financial reports on asset deployment.
MEDIUM RISK
Expansion financed by significant debt introduces financial and execution risks.
💡 Investor Takeaway
Anuh Pharma's board approved investment in manufacturing assets for expansion and plans to avail a loan of up to ₹ 75 crs to fund these purchases.
⚖️ Strengths & Concerns
✅ Positives
- Board approval for investment in manufacturing assets to expand production capacity.
- Proposal to avail loan up to ₹ 75 crs for asset acquisition and expansion.
❓ Frequently Asked Questions
What has Anuh Pharma's board approved?
The board approved investment in manufacturing assets for expansion and a proposal to avail a loan of up to ₹ 75 crs.
What is the purpose of the loan?
The loan of up to ₹ 75 crs is for the purchase of manufacturing assets to expand the company's production capacity.
When was this decision made?
The Board of Directors approved these proposals at their meeting held on Tuesday, 13th October, 2026.
What is the amount of the proposed loan?
The company proposes to avail a loan of up to ₹ 75 crs (Rupees Seventy Five Crores).
Questions based on this BSE filing only. For information purposes.